Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Commentary

  • 1,895 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • …
  • 138
  • 139
  • 140
  • …
  • 189
  • 190
  • Next →
Skeletal muscle fat oxidation: timing and flexibility are everything
David E. Kelley
David E. Kelley
Published July 1, 2005
Citation Information: J Clin Invest. 2005;115(7):1699-1702. https://doi.org/10.1172/JCI25758.
View: Text | PDF

Skeletal muscle fat oxidation: timing and flexibility are everything

  • Text
  • PDF
Abstract

In order to examine the factors governing the timing and flexibility of skeletal muscle switching between fat and carbohydrate oxidation, Ukropcova et al. studied the effect of glucose and fatty acid availability on the preference for fat oxidation in myocytes cultured from human male quadriceps muscle taken from subjects with varied BMI, fat mass, and insulin sensitivity. The authors found that in vivo insulin sensitivity was related to a higher in vitro capacity for fat oxidation. These findings support the concept that the capacity of skeletal muscle to oxidize fat under appropriate physiological conditions is related to leanness, aerobic fitness, and insulin sensitivity.

Authors

David E. Kelley

×

HIF-1α: a master regulator of innate host defenses?
Kol A. Zarember, Harry L. Malech
Kol A. Zarember, Harry L. Malech
Published July 1, 2005
Citation Information: J Clin Invest. 2005;115(7):1702-1704. https://doi.org/10.1172/JCI25740.
View: Text | PDF

HIF-1α: a master regulator of innate host defenses?

  • Text
  • PDF
Abstract

In the days following infection, when the human body develops and refines antibodies and prepares to mount an adaptive immune response, the bulwark of innate host defense against microbial infection is the polymorphonuclear leukocyte (PMN). PMNs seek out, identify, engulf, and sterilize invading microbes using both O2-dependent and O2-independent antimicrobial systems. A decrease in PMN numbers or function caused by immunosuppression or disease increases the risk of infection. In this issue of the JCI, Peyssonnaux et al. identify a novel and essential role for hypoxia-inducible factor–1α in regulating several important PMN functions relevant to host defense, including transcription of cationic antimicrobial polypeptides and induction of NO synthase.

Authors

Kol A. Zarember, Harry L. Malech

×

Bone marrow plasticity revisited: protection or differentiation in the kidney tubule?
Diane Krause, Lloyd G. Cantley
Diane Krause, Lloyd G. Cantley
Published July 1, 2005
Citation Information: J Clin Invest. 2005;115(7):1705-1708. https://doi.org/10.1172/JCI25540.
View: Text | PDF

Bone marrow plasticity revisited: protection or differentiation in the kidney tubule?

  • Text
  • PDF
Abstract

Epithelial organs such as the intestine and skin have a relatively high rate of cell loss and thus require a reservoir of stem cells capable of both replacing the lost epithelia and maintaining the reservoir. Whether the kidney has such a stem cell niche has been a subject of great interest; the majority of data suggest that replacement of renal epithelial cells occurs via dedifferentiation and proliferation of existing tubular cells, while some studies demonstrate the presence of potential tubular stem cells in the renal interstitium. However, recent reports have suggested that the bone marrow may also be a source of stem cells for tubule turnover and/or repair. In this issue of the JCI, 2 groups explore the role of endogenous cells versus bone marrow–derived cells in mediating tubule repair. Duffield and colleagues demonstrate that bone marrow does contain cells capable of protecting the kidney from ischemic injury, but found that these cells do not act by direct incorporation into the repaired tubular segments. In contrast, Lin and coworkers found that some bone marrow–derived cells do appear to incorporate into the injured tubule as epithelial cells (see the related article beginning on page 1756). Importantly, both groups conclude that the majority of tubule repair occurs via proliferation of endogenous renal cells rather than incorporation of bone marrow–derived cells.

Authors

Diane Krause, Lloyd G. Cantley

×

Harlequin ichthyosis unmasked: a defect of lipid transport
Alain Hovnanian
Alain Hovnanian
Published July 1, 2005
Citation Information: J Clin Invest. 2005;115(7):1708-1710. https://doi.org/10.1172/JCI25736.
View: Text | PDF

Harlequin ichthyosis unmasked: a defect of lipid transport

  • Text
  • PDF
Abstract

Harlequin ichthyosis (HI) — the most severe form of keratinizing disorders, often lethal in the neonatal period — is characterized by a profound thickening of the keratin skin layer, a dense “armor”-like scale that covers the body, and contraction abnormalities of the eyes, ears, and mouth. In this issue of the JCI, Akiyama et al. report that mutations in ABCA12 caused defective lipid transport that significantly impacted normal development of the skin barrier. Lipid secretion was recovered after corrective ABCA12 gene transfer into patient keratinocytes. These results should allow for early prenatal diagnosis of HI and lend hope to the possibility of a specific treatment for this devastating disorder.

Authors

Alain Hovnanian

×

Chromogranin A: a surprising link between granule biogenesis and hypertension
Taeyoon Kim, Y. Peng Loh
Taeyoon Kim, Y. Peng Loh
Published July 1, 2005
Citation Information: J Clin Invest. 2005;115(7):1711-1713. https://doi.org/10.1172/JCI25706.
View: Text | PDF

Chromogranin A: a surprising link between granule biogenesis and hypertension

  • Text
  • PDF
Abstract

Chromogranin A (CHGA) and its derived peptides, which are stored and released from dense-core secretory granules of neuroendocrine cells, have been implicated as playing multiple roles in the endocrine, cardiovascular, and nervous systems. In this issue of the JCI, Mahapatra et al. present in vivo evidence for 2 important functions of CHGA: the regulation of catecholamine-containing dense-core chromaffin granule biogenesis in the adrenal gland and the control of blood pressure. Obliteration of CHGA expression in a KO mouse model led to decreased size and number of chromaffin granules as well as hypertension in these animals. Transgenic expression of human Chga and exogenous injection of human catestatin, a CHGA-derived nicotinic cholinergic antagonist, restored normal blood pressure in these mice. These results suggest a coupled relationship between CHGA-mediated chromaffin granule biogenesis, necessary for catecholamine storage, and catestatin-induced inhibition of cholinergic-stimulated catecholamine release, which regulates autonomic control of blood pressure.

Authors

Taeyoon Kim, Y. Peng Loh

×

Atrial natriuretic peptide: an essential physiological regulator of transvascular fluid, protein transport, and plasma volume
Fitz-Roy E. Curry
Fitz-Roy E. Curry
Published June 1, 2005
Citation Information: J Clin Invest. 2005;115(6):1458-1461. https://doi.org/10.1172/JCI25417.
View: Text | PDF

Atrial natriuretic peptide: an essential physiological regulator of transvascular fluid, protein transport, and plasma volume

  • Text
  • PDF
Abstract

Atrial natriuretic peptide (ANP) acts acutely to reduce plasma volume by at least 3 mechanisms: increased renal excretion of salt and water, vasodilation, and increased vascular permeability. Authors of a study in this issue of the JCI performed a knockout of the receptor for ANP in vascular endothelia in order to distinguish the effects of ANP-dependent increases in vascular permeability from those of other endocrine actions of ANP in the regulation of plasma volume. The knockout mice exhibited reduced vascular permeability to plasma protein, resulting in chronically increased plasma volume, arterial hypertension, and cardiac hypertrophy. Renal excretion and vasodilation did not account for these changes. Thus ANP-induced increases in endothelial permeability may be critical to the ability of ANP to lower arterial blood pressure.

Authors

Fitz-Roy E. Curry

×

Lessons learned from cancer may help in the treatment of pulmonary hypertension
Serge Adnot
Serge Adnot
Published June 1, 2005
Citation Information: J Clin Invest. 2005;115(6):1461-1463. https://doi.org/10.1172/JCI25399.
View: Text | PDF

Lessons learned from cancer may help in the treatment of pulmonary hypertension

  • Text
  • PDF
Abstract

Hyperplasia of pulmonary artery SMCs (PASMCs) is a pathological hallmark of pulmonary arterial hypertension (PAH). In this issue of the JCI, McMurtry et al. report that adenovirus-mediated overexpression of survivin — a multipotent inhibitor of apoptosis — induces PAH in rats, whereas inhalation of an adenovirus vector encoding a mutant survivin gene with dominant-negative properties reverses established monocrotaline-induced PAH. These findings raise important issues regarding the role of survivin in the pathogenesis of PAH, its value as a prognostic indicator, and its use as a target for new therapeutic strategies.

Authors

Serge Adnot

×

Stem cell–ness: a “magic marker” for cancer
John P. Lahad, … , Gordon B. Mills, Kevin R. Coombes
John P. Lahad, … , Gordon B. Mills, Kevin R. Coombes
Published June 1, 2005
Citation Information: J Clin Invest. 2005;115(6):1463-1467. https://doi.org/10.1172/JCI25455.
View: Text | PDF | Erratum

Stem cell–ness: a “magic marker” for cancer

  • Text
  • PDF
Abstract

Transcriptional profiling of patient tumors is a much-heralded advancement in cancer therapy, as it provides the opportunity to identify patients who would benefit from more or less aggressive therapy and thus allows the development of individualized treatment. However, translation of this promise into patient benefit has proven challenging. In this issue of the JCI, Glinsky and colleagues used human and murine models to identify a potential stem cell mRNA signature, based on the hypothesis that tumors with stem cell–like characteristics are likely to have a poor prognosis. Remarkably, an 11-gene “expression signature” associated with “stem cell–ness” separated patients with different cancers into good- and poor-prognosis groups. Such a “magic marker” would, if validated, have a major impact on patient care. However, there remain challenges incumbent with creating and validating such signatures.

Authors

John P. Lahad, Gordon B. Mills, Kevin R. Coombes

×

Toward improved immunocompetence of adoptively transferred CD8+ T cells
Daniel E. Speiser, Pedro Romero
Daniel E. Speiser, Pedro Romero
Published June 1, 2005
Citation Information: J Clin Invest. 2005;115(6):1467-1469. https://doi.org/10.1172/JCI25427.
View: Text | PDF

Toward improved immunocompetence of adoptively transferred CD8+ T cells

  • Text
  • PDF
Abstract

Adoptive transfer of autologous or allogenic T cells to patients is being used with increased frequency as a therapy for infectious diseases and cancer. However, many questions remain with regard to defining optimized procedures for preparation and selection of T cell populations for transfer. In a new study in this issue of the JCI, Gattinoni and colleagues used a TCR transgenic mouse model to examine in vitro–generated tumor antigen–specific CD8+ T cells at various stages of differentiation for their efficacy in adoptive immunotherapy against transplantable melanoma. The results confirm that CD8+ T cells progressively lose immunocompetence with prolonged in vitro cultivation and suggest that effector CD8+ T cells alone may be considerably less potent at protecting hosts with advanced tumors than are less differentiated T cells.

Authors

Daniel E. Speiser, Pedro Romero

×

Understanding globin regulation in β-thalassemia: it’s as simple as α, β, γ, δ
Arthur Bank
Arthur Bank
Published June 1, 2005
Citation Information: J Clin Invest. 2005;115(6):1470-1473. https://doi.org/10.1172/JCI25398.
View: Text | PDF

Understanding globin regulation in β-thalassemia: it’s as simple as α, β, γ, δ

  • Text
  • PDF
Abstract

A vast excess of α-globin production and inadequate γ-globin compensation lead to the development of severe anemia in human β-thalassemia. Newly identified modifiers of α- and γ-globin synthesis and insights into the mechanisms of globin regulation provide the tools for potential new approaches to treating this and other red blood cell disorders. In the study by Han and colleagues in this issue of the JCI, the activity of a heme-regulated protein, HRI, is shown to modulate the accumulation of excess α-globin chains in murine β-thalassemia and to decrease the severity of the disease.

Authors

Arthur Bank

×
  • ← Previous
  • 1
  • 2
  • …
  • 138
  • 139
  • 140
  • …
  • 189
  • 190
  • Next →

No posts were found with this tag.

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts